Form 8-K - Current report:
SEC Accession No. 0001640334-24-000184
Filing Date
2024-02-06
Accepted
2024-02-06 16:15:19
Documents
18
Period of Report
2024-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmmj_8k.htm   iXBRL 8-K 35921
2 MEMBERSHIP INTEREST PURCHASE AGREEMENT bmmj_ex101.htm EX-10.1 323506
3 LETTER AGREEMENT bmmj_ex102.htm EX-10.2 73375
  Complete submission text file 0001640334-24-000184.txt   638901

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20240131.xsd EX-101.SCH 5720
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20240131_lab.xml EX-101.LAB 13114
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20240131_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20240131_pre.xml EX-101.PRE 8222
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20240131_def.xml EX-101.DEF 2099
19 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_8k_htm.xml XML 3533
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-55940 | Film No.: 24600452
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)